Monthly Archives: September 2016

In local news:

Louisiana Insurance Commissioner Jim Donelon issued a press release discussing Louisiana’s higher than average opioid abuse rates and urging action.

In pharmacy news:

More than a quarter of the Food and Drug Administration employees who approved cancer and hematology drugs from 2001 through 2010 left the agency and now work or consult for pharmaceutical companies, according to new research published by the BMJ.

In local news:

The Advocate reported that four men injured in a 2013 explosion at the Williams Olefins Geismar plant were awarded a total of $13.6 million in damages from an Iberville Parish jury.

In national news:

The Maine Workers’ Compensation Board has ruled that two Maine employers must pay for medical marijuana, becoming the third state to make such a determination.

In medical news:

A new retrospective study found that prescribing long-acting opioids for moderate to severe chronic noncancer pain is linked to higher rates of death than alternative medications.

In continuing news:

The Florida Office of Insurance Regulation has issued an Order that gives contingent approval to an overall combined average statewide rate increase of 14.5 percent versus the NCCI requested 19.6 percent.

Louisiana Commission on Preventing Opioid Abuse Gets to Work in Baton Rouge with 2/17 Deadline

The inaugural meeting of the Louisiana Commission on Preventing Opioid Abuse was held yesterday at the Department of Health in Baton Rouge. The Commission is the result of HCR 113, a resolution passed in the last regular legislative session and is co-chaired by Malcolm Broussard of the Louisiana Board of Pharmacy and Eric D. Torres of the Louisiana State Board of Medical Examiners.